WebBiora Therapeutics Stock Target Price and Analyst Consensus. Buy or Sell News Calendar Exposure. BIOR Stock. USD 4.77 0.34 7.67%. Analysts of Biora Therapeutics render … WebBiora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2024 Earnings Call Transcript This is the conference operator. Welcome to the Biora Therapeutics Fourth Quarter 2024 Financial …
Biora Therapeutics Inc (BIOR) AAII Stock Evaluator
WebApr 10, 2024 · The latest price target for . Biora Therapeutics (NASDAQ: BIOR) was reported by HC Wainwright & Co. on Tuesday, January 10, 2024.The analyst firm set a … WebView real-time BIOR stock price and news, along with industry-best analysis. ... Average price target from 2 ratings: $82.50. Average score: Sell. Under. Hold. Over. Buy. Full Ratings. Open. $2.7000. cyprian twitter
Biora Therapeutics, Inc. (BIOR) Wall St. Analysts Rating
WebMar 24, 2024 · Biora Therapeutics, Inc., formerly Progenity, Inc., is a biotechnology company focused on developing oral biotherapeutics. It delivers therapeutics in two areas: targeted delivery of therapeutics to the site of disease in the gastrointestinal tract and systemic delivery of biotherapeutics. Its research and development pipeline consists of … WebApr 4, 2024 · View BIOR revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $100.00: Low: $65.00: Average: $82.50: Current Price: $3.5100: BIOR will ... WebApr 11, 2024 · Is Biora Therapeutics (NASDAQ:BIOR) the best stock in the Pharmaceutical preparations industry? Compare top BIOR competitors at MarketBeat. Is Biora Therapeutics (NASDAQ:BIOR) the best stock in the Pharmaceutical preparations industry? ... Share Price Analysts' Price Target 1Y Price Performance Market Cap Revenue P/E Ratio Employee … cyprian wright